Document -
Athera allowed European composition of matter patents for therapeutic antibodies
Athera today announced that a composition of matter patent covering antibodies with binding to phosphorylcholine, PC has been allowed by the European Patent Office. The therapeutic antibodies are designed to reduce vascular inflammation. The EPO allowance is following the previous grant of corresponding US, Japanese and Australian patents covering the lead candidate PC-mAb and a second candidate.
-
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
- File format: .pdf
